Cargando…

Lacrimal Gland Histopathology and Secretory Function in Sjögren’s Syndrome Mice Model Treated with Moringa oleifera Lam. Leaf Extract

BACKGROUND: The pathogenesis of Sjögren’s syndrome involves the activation of NF-κB, producing proinflammatory cytokines such as tumor necrosis factor-α, interleukin (IL)-1α, IL-1β, IL-6, IL-17, and interferon-γ. Through oxidative stress, they will cause necrosis and apoptosis of lacrimal gland cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Susanto, Agus Joko, Purwanto, Bambang, Mudigdo, Ambar, Wasita, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226169/
https://www.ncbi.nlm.nih.gov/pubmed/36305140
http://dx.doi.org/10.2174/1871523022666221026145110
_version_ 1785050521423314944
author Susanto, Agus Joko
Purwanto, Bambang
Mudigdo, Ambar
Wasita, Brian
author_facet Susanto, Agus Joko
Purwanto, Bambang
Mudigdo, Ambar
Wasita, Brian
author_sort Susanto, Agus Joko
collection PubMed
description BACKGROUND: The pathogenesis of Sjögren’s syndrome involves the activation of NF-κB, producing proinflammatory cytokines such as tumor necrosis factor-α, interleukin (IL)-1α, IL-1β, IL-6, IL-17, and interferon-γ. Through oxidative stress, they will cause necrosis and apoptosis of lacrimal gland cells, resulting in impaired secretory function or reduced tear production. Moringa oleifera leaf extract is known to have strong anti-inflammatory and antioxidant activities. OBJECTIVE: To determine the effect of Moringa oleifera leaf extract on lacrimal gland histopathology and secretory function in Sjögren’s syndrome mice model. METHODS: The experimental study had a post-test only control group design with 32 eight-week-old male mice of the BALB/c strain divided into four groups, negative control (C−), which was not induced by SS, positive control (C+), treatment 1 (T1), and treatment 2 (T2) induced by Sjögren’s syndrome by immunizing with the 60-kD Ro antigen (SSA) as much as 100 µg. After 42 days, the T1 group was given dexamethasone 1.23 mg/kg BW/day orally for 14 days, whereas T2 was given dexamethasone 1.23 mg/kg BW/day and Moringa oleifera leaf ethanol extract 200 mg/kg BW/day orally for 14 days. At the end of the study, lacrimal gland histopathology and secretory function (tear production) were examined. Statistical analysis using F ANOVA/Kruskal-Wallis was followed by partial difference test with the Least Significant Difference post hoc test/Mann-Whitney. Significant if p < 0.05. RESULTS: The comparison of lacrimal gland histopathology in T1 (p = 0.044) and T2 groups (p = 0.020) obtained significant results (p < 0.05) when compared to C+. However, the comparison of tear production in T1 (p = 0.127) and T2 groups (p = 0.206) was not significant (p > 0.05) when compared to the C+ group. CONCLUSION: The administration of Moringa oleifera leaf extract 200 mg/kg BW for 14 days could significantly improve lacrimal gland histopathology but was not effective in increasing tear production in Sjögren’s syndrome mice model.
format Online
Article
Text
id pubmed-10226169
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-102261692023-05-30 Lacrimal Gland Histopathology and Secretory Function in Sjögren’s Syndrome Mice Model Treated with Moringa oleifera Lam. Leaf Extract Susanto, Agus Joko Purwanto, Bambang Mudigdo, Ambar Wasita, Brian Antiinflamm Antiallergy Agents Med Chem Inflammation and Allergy; Discovery and Therapy, Drug Design & Discovery, Medicine, Immunology, Pharmacology BACKGROUND: The pathogenesis of Sjögren’s syndrome involves the activation of NF-κB, producing proinflammatory cytokines such as tumor necrosis factor-α, interleukin (IL)-1α, IL-1β, IL-6, IL-17, and interferon-γ. Through oxidative stress, they will cause necrosis and apoptosis of lacrimal gland cells, resulting in impaired secretory function or reduced tear production. Moringa oleifera leaf extract is known to have strong anti-inflammatory and antioxidant activities. OBJECTIVE: To determine the effect of Moringa oleifera leaf extract on lacrimal gland histopathology and secretory function in Sjögren’s syndrome mice model. METHODS: The experimental study had a post-test only control group design with 32 eight-week-old male mice of the BALB/c strain divided into four groups, negative control (C−), which was not induced by SS, positive control (C+), treatment 1 (T1), and treatment 2 (T2) induced by Sjögren’s syndrome by immunizing with the 60-kD Ro antigen (SSA) as much as 100 µg. After 42 days, the T1 group was given dexamethasone 1.23 mg/kg BW/day orally for 14 days, whereas T2 was given dexamethasone 1.23 mg/kg BW/day and Moringa oleifera leaf ethanol extract 200 mg/kg BW/day orally for 14 days. At the end of the study, lacrimal gland histopathology and secretory function (tear production) were examined. Statistical analysis using F ANOVA/Kruskal-Wallis was followed by partial difference test with the Least Significant Difference post hoc test/Mann-Whitney. Significant if p < 0.05. RESULTS: The comparison of lacrimal gland histopathology in T1 (p = 0.044) and T2 groups (p = 0.020) obtained significant results (p < 0.05) when compared to C+. However, the comparison of tear production in T1 (p = 0.127) and T2 groups (p = 0.206) was not significant (p > 0.05) when compared to the C+ group. CONCLUSION: The administration of Moringa oleifera leaf extract 200 mg/kg BW for 14 days could significantly improve lacrimal gland histopathology but was not effective in increasing tear production in Sjögren’s syndrome mice model. Bentham Science Publishers 2022-03-03 2022-03-03 /pmc/articles/PMC10226169/ /pubmed/36305140 http://dx.doi.org/10.2174/1871523022666221026145110 Text en © 2022 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Inflammation and Allergy; Discovery and Therapy, Drug Design & Discovery, Medicine, Immunology, Pharmacology
Susanto, Agus Joko
Purwanto, Bambang
Mudigdo, Ambar
Wasita, Brian
Lacrimal Gland Histopathology and Secretory Function in Sjögren’s Syndrome Mice Model Treated with Moringa oleifera Lam. Leaf Extract
title Lacrimal Gland Histopathology and Secretory Function in Sjögren’s Syndrome Mice Model Treated with Moringa oleifera Lam. Leaf Extract
title_full Lacrimal Gland Histopathology and Secretory Function in Sjögren’s Syndrome Mice Model Treated with Moringa oleifera Lam. Leaf Extract
title_fullStr Lacrimal Gland Histopathology and Secretory Function in Sjögren’s Syndrome Mice Model Treated with Moringa oleifera Lam. Leaf Extract
title_full_unstemmed Lacrimal Gland Histopathology and Secretory Function in Sjögren’s Syndrome Mice Model Treated with Moringa oleifera Lam. Leaf Extract
title_short Lacrimal Gland Histopathology and Secretory Function in Sjögren’s Syndrome Mice Model Treated with Moringa oleifera Lam. Leaf Extract
title_sort lacrimal gland histopathology and secretory function in sjögren’s syndrome mice model treated with moringa oleifera lam. leaf extract
topic Inflammation and Allergy; Discovery and Therapy, Drug Design & Discovery, Medicine, Immunology, Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226169/
https://www.ncbi.nlm.nih.gov/pubmed/36305140
http://dx.doi.org/10.2174/1871523022666221026145110
work_keys_str_mv AT susantoagusjoko lacrimalglandhistopathologyandsecretoryfunctioninsjogrenssyndromemicemodeltreatedwithmoringaoleiferalamleafextract
AT purwantobambang lacrimalglandhistopathologyandsecretoryfunctioninsjogrenssyndromemicemodeltreatedwithmoringaoleiferalamleafextract
AT mudigdoambar lacrimalglandhistopathologyandsecretoryfunctioninsjogrenssyndromemicemodeltreatedwithmoringaoleiferalamleafextract
AT wasitabrian lacrimalglandhistopathologyandsecretoryfunctioninsjogrenssyndromemicemodeltreatedwithmoringaoleiferalamleafextract